Procter Gamble Health Stock Current Valuation
| PGHL Stock | 5,600 4.75 0.08% |
Valuation analysis of Procter Gamble Health helps investors to measure Procter Gamble's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, Procter Gamble's Cash is comparatively stable compared to the past year. Cash And Short Term Investments is likely to gain to about 3.7 B in 2024, despite the fact that Other Cashflows From Financing Activities is likely to grow to (29.6 M). Fundamental drivers impacting Procter Gamble's valuation include:
Price Book 17.2705 | Enterprise Value 90.5 B | Enterprise Value Ebitda 30.0169 | Price Sales 7.9579 | Trailing PE 42.429 |
Fairly Valued
Today
Please note that Procter Gamble's price fluctuation is very steady at this time. Calculation of the real value of Procter Gamble Health is based on 3 months time horizon. Increasing Procter Gamble's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Procter stock is determined by what a typical buyer is willing to pay for full or partial control of Procter Gamble Health. Since Procter Gamble is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procter Stock. However, Procter Gamble's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 5600.0 | Real 5462.38 | Hype 5615.63 | Naive 5960.58 |
The intrinsic value of Procter Gamble's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Procter Gamble's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Procter Gamble Health helps investors to forecast how Procter stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procter Gamble more accurately as focusing exclusively on Procter Gamble's fundamentals will not take into account other important factors: Procter Gamble Health Company Current Valuation Analysis
Procter Gamble's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Procter Gamble Current Valuation | 90.48 B |
Most of Procter Gamble's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Procter Gamble Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Procter Gamble Health has a Current Valuation of 90.48 B. This is much higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The current valuation for all India stocks is significantly lower than that of the firm.
Procter Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Procter Gamble's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Procter Gamble could also be used in its relative valuation, which is a method of valuing Procter Gamble by comparing valuation metrics of similar companies.Procter Gamble is currently under evaluation in current valuation category among its peers.
Procter Fundamentals
| Return On Equity | 0.31 | ||||
| Return On Asset | 0.18 | ||||
| Profit Margin | 0.19 % | ||||
| Operating Margin | 0.35 % | ||||
| Current Valuation | 90.48 B | ||||
| Shares Outstanding | 16.6 M | ||||
| Shares Owned By Insiders | 52.17 % | ||||
| Shares Owned By Institutions | 16.54 % | ||||
| Price To Book | 17.27 X | ||||
| Price To Sales | 7.96 X | ||||
| Revenue | 11.51 B | ||||
| Gross Profit | 8.68 B | ||||
| EBITDA | 3.07 B | ||||
| Net Income | 2.01 B | ||||
| Cash And Equivalents | 3.4 B | ||||
| Total Debt | 95.6 M | ||||
| Book Value Per Share | 324.29 X | ||||
| Cash Flow From Operations | 2.28 B | ||||
| Earnings Per Share | 131.04 X | ||||
| Beta | 0.51 | ||||
| Market Capitalization | 92.29 B | ||||
| Total Asset | 7.94 B | ||||
| Retained Earnings | 3.71 B | ||||
| Working Capital | 3.05 B | ||||
| Annual Yield | 0.02 % | ||||
| Net Asset | 7.94 B |
About Procter Gamble Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Procter Gamble Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Procter Gamble using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Procter Gamble Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Procter Stock Analysis
When running Procter Gamble's price analysis, check to measure Procter Gamble's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Procter Gamble is operating at the current time. Most of Procter Gamble's value examination focuses on studying past and present price action to predict the probability of Procter Gamble's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Procter Gamble's price. Additionally, you may evaluate how the addition of Procter Gamble to your portfolios can decrease your overall portfolio volatility.